Loewen Andrea - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 26, 2023, Loewen Andrea's relationship to REATA PHARMACEUTICALS INC (RETA) is Officer (SVP, Global Regulatory Affairs), and currently has 0 shares of Class A common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RETA insiders.
Data Source: SEC.
Loewen Andrea - Insider Non-Derivative Transactions of RETA Class A common stock
Loewen Andrea - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 27, 2023 | Disposition -- (Class A common stock) | 28416 | 0 | 0 |
| Sep 15, 2023 | Sell -- (Class A common stock) | 3175 | 172.03 | 28416 |
| May 17, 2023 | Sell -- (Class A common stock) | 313 | 81.02 | 31591 |
| May 16, 2023 | Sell -- (Class A common stock) | 103 | 84.71 | 31904 |
| May 13, 2023 | Sell -- (Class A common stock) | 6750 | 86.26 | 32007 |
| Mar 8, 2023 | Sell -- (Class A common stock) | 1200 | 84.44 | 38757 |
| Mar 8, 2023 | Sell -- (Class A common stock) | 17836 | 83.36 | 39957 |
| Mar 8, 2023 | M -- (Class A common stock) | 15000 | 27.32 | 57793 |
| Mar 4, 2023 | Sell -- (Class A common stock) | 1601 | 87.73 | 42793 |
| Mar 3, 2023 | Sell -- (Class A common stock) | 218 | 90.61 | 44394 |
| Jan 4, 2023 | Acquisition -- (Class A common stock) | 11756 | 0 | 44612 |